Blueprint Medicines Corp (BPMC)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

45 SIDNEY STREET CAMBRIDGE, MA 02139

Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, the company creates therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, Blueprint has leveraged its research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, the company is delivering its approved medicines to patients in the United States and Europe, and the company is globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.

Data as of 2021-08-02 08:44:52 -0400
Market Cap5.147 Billion Shares Outstanding58.574 Million Avg 30-day Volume442.031 Thousand
P/E Ratio15.13113 Dividend Yield EPS5.81
Price/Sales6.22 Debt to Equity1.18 EBITDA345.173 Million
Price to Book Value3.87 Forward PE-13.37 Enterprise Value4.519 Billion
Total Cash628.349 Million Current Debt125.397 Million Gross Profit821.227 Million
BETA1.05479 52-week High/Low125.61 / 66.2 Next Earnings Date Price to Cash FLow (P/CF) -51.1299
Data provided by IEX Cloud
View SEC Filings from BPMC instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 7 7 0.0% 5 (0.29%) 5 (0.29%) 0.0%
Funds Holding: 254 274 -7.3% 78 (4.58%) 93 (5.4%) -16.13%
13F shares: 57.734 Million 57.193 Million 0.95% 22.489 Million 21.824 Million 3.05%
% Ownership 99.6144 38.8019 39.1594 -0.91%
New Positions: 33 70 -52.86% 11 28 -60.71%
Increased Positions 101 73 38.36% 29 17 70.59%
Closed Positions 47 27 74.07% 22 12 83.33%
Reduced Positions 91 102 -10.78% 33 37 -10.81%
Total Calls 74.535 Thousand 225.708 Thousand -66.98% 10.9 Thousand 80.1 Thousand -86.39%
Total Puts 165.128 Thousand 711.728 Thousand -76.8% 127.423 Thousand 253.423 Thousand -49.72%
PUT/CALL Ratio 2.22 3.15 -29.52% 11.69 3.16 269.94%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BPMC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BPMC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

1 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAVILAND KATE CHIEF OPERATING OFFICER

  • Officer
56,539 2021-06-28 7

DEMETRI GEORGE

  • Director
10,312 2021-06-02 3

BORISY ALEXIS

  • Director
71,218 2021-06-02 1

LYDON NICHOLAS

  • Director
44,175 2021-06-02 3

ROWLAND CHARLES A JR

  • Director
10,312 2021-06-02 3

GOLDBERG MARK ALAN

  • Director
10,312 2021-06-02 7

COATS LONNEL

  • Director
10,312 2021-06-02 1

SEELY LYNN

  • Director
10,312 2021-06-02 1

HURLEY ARIEL PRINCIPAL ACCOUNTING OFFICER

  • Officer
10,097 2021-06-01 10

CARTER PERCY H. CHIEF SCIENTIFIC OFFICER

  • Officer
61,043 2021-06-01 2

ALBERS JEFFREY W. CEO AND PRESIDENT

  • Officer
  • Director
461,351 2021-05-12 7

LANDSITTEL MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
28,905 2021-03-04 2

MCCAIN TRACEY L EVP AND CHIEF LEGAL OFFICER

  • Officer
32,852 2021-03-04 2

MURRAY CHRISTOPHER K. SVP, TECHNICAL OPERATIONS

  • Officer
18,888 2021-03-04 2

ROSSI CHRISTINA CHIEF COMMERCIAL OFFICER

  • Officer
31,723 2021-03-04 3

DURSO-BUMPUS DEBRA CHIEF PEOPLE OFFICER

  • Officer
30,874 2021-03-04 3

NAMOUNI FOUAD PRESIDENT, R & D

  • Officer
71,687 2021-03-01 3

HEWES L. BECKER CHIEF MEDICAL OFFICER

  • Officer
56,687 2021-03-01 2

DORSCH MARION CHIEF SCIENTIFIC OFFICER

  • Officer
55,672 2021-02-22 4

BORAL ANTHONY L. CHIEF MEDICAL OFFICER

  • Officer
28,147 2020-12-14 4

LYNCH DANIEL

  • Director
127,904 2020-06-24 0

LEVIN MARK J

  • 10% Owner
3,564,997 2017-03-16 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
3,770,987 2017-02-27 0

STARR KEVIN P

  • 10% Owner
5,453,753 2016-12-19 0

LENGAUER CHRISTOPH CHIEF SCIENTIFIC OFFICER

  • Officer
56,657 2016-04-13 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2015-11-25 0

KUVALANKA KYLE D. CHIEF BUSINESS OFFICER

  • Officer
33,670 2015-04-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2021-06-30 16:02:49 -0400 2021-06-28 M 1,000 $36.05 a 54,948 direct yes -1.8595 -1.9279 0.0 1 -2.909 4

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2021-06-30 16:02:49 -0400 2021-06-28 S 622 $89.91 d 53,972 direct yes -1.8595 -1.9279 0.0 1 -2.909 4

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2021-06-30 16:02:49 -0400 2021-06-28 M 1,000 d 2,591 direct yes

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2021-06-30 16:02:49 -0400 2021-06-28 S 354 $90.88 d 54,594 direct yes -1.8595 -1.9279 0.0 1 -2.909 4

HAVILAND KATE - Officer CHIEF OPERATING OFFICER

2021-06-30 16:02:49 -0400 2021-06-28 S 24 $89.28 d 53,948 direct yes -1.8595 -1.9279 0.0 1 -2.909 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 22:15:04 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 21:45:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 21:15:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 20:45:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 20:15:04 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 19:45:04 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 19:15:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 18:45:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 18:15:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 17:45:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 17:15:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 16:45:02 UTC -0.2156 0.2956 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 16:15:03 UTC -0.2156 0.2956 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 15:45:03 UTC -0.2156 0.2956 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 15:15:02 UTC -0.2156 0.2956 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 14:45:02 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 14:15:04 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 13:45:04 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 13:15:03 UTC -0.17 0.25 750000
BLUEPRINT MEDICINES CORP BPMC 2021-08-05 12:45:03 UTC -0.17 0.25 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Advisors Series Trust- Pzena Long/Short Value Fund BPMC -1323.0 shares, $-86180.22 2020-05-31 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund BPMC -897.0 shares, $-69454.71 2020-08-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund BPMC -37.0 shares, $-2163.76 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund BPMC -25.0 shares, $-2317.5 2020-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BPMC -100.0 shares, $-9723.0 2021-03-31 N-PORT

Elevate your investments